PharmacoEconomics & Outcomes News Weekly

, Volume 160, Issue 1, pp 12–12 | Cite as

Obstacles to EC generic drug approval increase healthcare costs

Newsletter Article


Marketing European Community Healthcare Cost Product Characteristic Viable Option 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1998

Personalised recommendations